First Generic Flovent HFA Is Here. What It Could Mean for Asthma Patients and Families
FDA approved the first generic Flovent HFA, but access may still depend on strength, pharmacy supply, insurance coverage, and safe switching.
Health Costs & Coverage
Insurance coverage, out-of-pocket costs, benefits, billing, and access-related changes.
-
-
What ACA Marketplace shoppers should know about 2026 coverage after the latest federal changes
ACA Marketplace coverage in 2026 may require more paperwork, closer plan shopping, and higher premiums for some after extra tax-credit savings ended on Dec. 31, 2025.
-
ACA marketplace rules are changing for 2026: What health insurance shoppers should know
New federal ACA Marketplace rules for 2026 tighten some enrollment steps, though some provisions are on hold. Here’s what shoppers should do now.
-
FDA Is Tightening the Rules on Compounded GLP-1 Drugs. What That Could Mean for Access, Safety, and Cost
FDA’s 2026 crackdown on mass-marketed compounded GLP-1s could tighten safety oversight but also shrink cheaper options for people struggling to afford approved drugs.
-
Are Children’s Vaccines Still Covered? What the 2026 Schedule Fight Means for Parents
A plain-language guide to what changed in 2026, which vaccine schedule many pediatric practices and states are using, and how coverage works now for private insurance and VFC.
-
Gathered Healthcare Pricing Data | Health Costs & Coverage | Hospitals & Healthcare Systems | Medicare & CMS Updates
Hospital Price Transparency Rules Got Stricter on April 1, 2026. What Patients Can Actually Check Before Scheduling Care
CMS began enforcing updated hospital price transparency requirements on April 1, 2026. Here’s what patients can actually compare before planned care, what changed in hospital price files, and why the posted number is still not a final bill.
-
Medicare Changed Payment for Diabetic Foot Ulcer Skin Substitutes in 2026. What Patients Should Know
Medicare changed how it pays for many skin substitute products used in diabetic foot ulcers in 2026, but it did not broadly stop covering care. Here’s what the change may mean for access, treatment conversations, and when to seek help.
-
Will Medicare make Ozempic and Rybelsus cheaper? What people with diabetes should know now
The short answer is not yet. Medicare has selected Ozempic, Rybelsus, and Wegovy for drug price negotiation, but the negotiated Medicare price is not scheduled to begin until January 1, 2027. Here is what changed in 2026, why the timeline is confusing, and why your own costs can still vary by plan.
-
Men Get Osteoporosis Too: When to Ask About a Bone Density Scan
Osteoporosis is often treated like a women’s issue, but men can develop it too and may be diagnosed only after a serious fracture. Here is who should ask about a DXA bone density scan, how national policy differs from specialty guidance, and what Medicare may or may not cover.
-
First Generic Flovent HFA Approved: What People With Asthma Should Know About Cost, Coverage, and Daily Control
The FDA has approved the first generic of Flovent HFA, but this is not a simple fix for every family affected by the brand-name inhaler’s discontinuation. Here’s what changed, who it may help, and why coverage and pharmacy access may still be uneven.
-
Medicare Price Talks Are Moving Toward More Arthritis Drugs: What Patients Taking Xeljanz, Orencia, Cosentyx, or Cimzia Should Know
As of April 2, 2026, nothing changes at the pharmacy yet for Medicare patients taking Xeljanz, Orencia, Cosentyx, or Cimzia. What changed is that Medicare has selected these drugs for its third negotiation cycle, manufacturers are participating, and any negotiated prices would not begin until January 1, 2028.
-
Gathered Healthcare Pricing Data | Health Costs & Coverage | Healthcare Price Contributed Data | Medicare & CMS Updates
Hospital price transparency rules get tougher April 1: what patients may actually notice
Federal enforcement of updated hospital price transparency requirements begins April 1, 2026. That may make some hospital price listings more useful for planned care, but posted prices still are not the same as your final out-of-pocket bill.
-
ACA Marketplace Coverage Got More Expensive in 2026. What to Do if Premiums Are Higher or You Missed Open Enrollment
ACA Marketplace sign-ups for 2026 came in below last year, and many households are paying more after tax credits. Here is what changed, who may still qualify to enroll, and what to do if your plan or subsidy looks wrong.
-
ACA Marketplace in 2026: Why Updating Your Income Matters More Than Ever
If you get Marketplace premium help in 2026, the financial stakes are higher than they were before. Extra pandemic-era subsidy boosts have ended, and for tax years after 2025 there is no repayment cap if you get too much advance premium tax credit. Here’s what that means, who should act now, and where to get help.
-
ACA Marketplace Premiums Are Higher in 2026: What to Know Before You Lose Coverage or Owe Back Tax Credits
Many ACA Marketplace enrollees are paying more in 2026 after enhanced subsidies ended. If you already signed up, now is the time to verify premium payments, update your income information, and understand the risk of retroactive coverage loss or a tax-time payback.
-
Gathered Healthcare Pricing Data | Health Costs & Coverage | Hospitals & Healthcare Systems | Medicare & CMS Updates
CMS changed hospital price files for 2026. Will it be easier to compare health care prices?
CMS now requires hospitals to report clearer dollar-based pricing fields in their machine-readable files for 2026. That could make gathered pricing data easier to analyze, but it still does not give most patients an exact out-of-pocket quote.
-
What Medicare Covers for Diabetic Foot Care in 2026—and When You Shouldn’t Wait for Your Next Foot Exam
Medicare covers some diabetes-related foot care in 2026, but not unlimited routine foot care for everyone. Here’s who qualifies for Part B foot exams and treatment every 6 months, what therapeutic shoes may be covered, what you may pay, and which symptoms should be checked sooner.
-
New U.S. cervical cancer screening guidance adds self-collected HPV testing: who it’s for, what changes in 2026, and when insurance coverage follows
A new federal update says self-collected HPV testing should be offered as an option for average-risk women ages 30 to 65. Here’s what changed, what did not, and why many insurance plans may not have to cover the new option with no out-of-pocket costs until plan years that start in 2027.
-
Breast Cancer Screening Now Starts at 40: What the Updated USPSTF Guidance Means for Women
The U.S. Preventive Services Task Force now recommends that most women start mammograms at age 40 instead of 50. Here’s what changed, what the evidence shows, and what it means for your health and insurance coverage.
-
Medicare Telehealth in 2026: What Extended Flexibilities Mean for Patients at Home
Medicare has extended many telehealth flexibilities through 2026. Here’s what that means for receiving care at home, what’s covered, what you pay, and what could change next.
-
Health Costs & Coverage | Healthcare Policy & Access | Psychiatry | Public Health Data & Surveillance
New Federal Data Show Where Mental Health Needs and Treatment Gaps Stand in 2026
The latest federal survey finds mental illness remains common in the U.S., especially among teens and young adults. Millions report serious symptoms each year, and many still do not receive treatment. Here’s what the newest data show—and what it means for families, insurance coverage, and when to seek help.
-
Will Medicare Cover Weight-Loss Drugs in 2026? What New Obesity Medications Mean for Access, Costs, and Care
New FDA-approved obesity medications have changed treatment options—but Medicare’s long-standing drug coverage rules still shape who can access them. Here’s what adults and families should understand in 2026 about eligibility, costs, and policy limits.
End of content
End of content
